Butylphthalide Placebo

DRUG3 trials

Sponsors

Beijing Tiantan Hospital, Xiangya Hospital of Central South University

Conditions

Acute Ischemic StrokeCerebral Small Vessel DiseasesST-segment Elevation Myocardial Infarction (STEMI)Stroke, Acute IschemicStroke, Lacunar

Phase 3

Efficacy and Safety of Butylphthalide for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis or Endovascular Treatment

CompletedNCT03539445

Beijing Tiantan HospitalAcute Ischemic Stroke

Start: 2018-07-01End: 2022-07-31Updated: 2022-08-05

A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction Size and Improving Outcomes in STEMI Patients After Primary PCI

Not yet recruitingNCT06704685

Xiangya Hospital of Central South UniversityST-segment Elevation Myocardial Infarction (STEMI)

Start: 2024-12-01End: 2025-12-31Target: 40Updated: 2024-11-26

Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT)

Not yet recruitingNCT07252544

Beijing Tiantan HospitalCerebral Small Vessel Diseases, Stroke, Acute Ischemic, Stroke, Lacunar

Start: 2025-12-01End: 2028-02-29Target: 3156Updated: 2025-11-26

Related Papers

Efficacy and Safety of Butylphthalide in Patients With Acute Ischemic Stroke

JAMA Neurology2023-06-26110 citations

Abstract 90: Butylphthalide Improves Functional Outcome In Patients With Acute Ischemic Stroke Receiving Intravenous Thrombolysis And/or Endovascular Treatment In Comparison To Placebo

Stroke2023-02-01

Efficacy and safety of butylphthalide for patients who had acute ischaemic stroke receiving intravenous thrombolysis or endovascular treatment (BAST trial): study protocol for a randomised placebo-controlled trial

BMJ Open2021-05-0112 citations